VG161

· CNBG-Virogin Biotech (Shanghai) Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for VG161, covering 2022-03-09 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I-II Study of Novel Oncolytic Virus VG161 Via Intravesical Instillation for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer [Phase 1, Phase 2]

See pricing